Financials GRAIL, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
97.50 ^USD	+1.68%		-2.89%	+13.92%

Feb. 04	Hims & Hers Health, Inc. Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care	CI
Feb. 04	Hims & Hers Offers Multi-Cancer Blood Screening Through New Partnership	MT

Fiscal Period: December	2023	2024	2025	2026	2027
Net sales ¹	93.1	125.6	147.1	176.7	220.7
Change	-	34.9%	17.1%	20.12%	24.96%
EBITDA ¹	-	-2,031	-382.1	-348.9	-352.1
Change	-	-	81.19%	8.71%	-0.92%
EBIT ¹	-	-2,189	-531.3	-508	-532.3
Change	-	-	75.73%	4.39%	-4.78%
Interest Paid	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-2,162	-544.3	-508.1	-517.2
Change	-	-	74.83%	6.65%	-1.8%
Net income ¹	-1,466	-2,027	-435.5	-508.1	-517.2
Change	-	-38.3%	78.52%	-16.67%	-1.8%
Announcement Date	5/6/24	2/20/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	28.65	38.25	31.84	35.54	36.19	43.33	38.23	44.05	43.9	52.35	50.9	60.5	61.6
Change	-	33.51%	-16.77%	11.64%	1.83%	19.73%	-11.77%	15.21%	-0.34%	19.25%	-2.77%	18.86%	1.82%
EBITDA ¹	-	-97.5	-98.7	-78.32	-71.7	-81.4	-86.6	-81.15	-81.55	-86.8	-84.3	-99.9	-101.3
Change	-	-	-1.23%	20.65%	8.45%	-13.52%	-6.39%	6.29%	-0.49%	-6.44%	2.88%	-18.51%	-1.4%
EBIT ¹	-183.5	-136.9	-153.6	-158.9	-125.3	-123	-122.6	-128.2	-128.8	-134.8	-125	-141.8	-143.3
Change	-	25.38%	-12.17%	-3.42%	21.13%	1.83%	0.33%	-4.57%	-0.43%	-4.7%	7.27%	-13.44%	-1.06%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-172.4	-127	-146.4	-152.9	-118.7	-125.4	-130.4	-125.2	-125.7	-131.8	-118.9	-135.7	-137.2
Change	-	26.34%	-15.29%	-4.4%	22.33%	-5.67%	-3.91%	3.99%	-0.44%	-4.81%	9.75%	-14.13%	-1.11%
Net income ¹	-125.7	-97.07	-106.2	-114	-88.98	-125.4	-130.4	-125.2	-125.7	-131.8	-118.9	-135.7	-137.2
Change	-	22.77%	-9.42%	-7.32%	21.94%	-40.99%	-3.91%	3.99%	-0.44%	-4.81%	9.75%	-14.13%	-1.11%
Announcement Date	11/12/24	2/20/25	5/13/25	8/12/25	11/12/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Net Debt ¹	-	-763	-797	-626	-336
Change	-	-	-4.39%	21.46%	46.33%
Announcement Date	5/6/24	2/20/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
CAPEX ¹	5.208	1.8	5.5	6.7
Change	-	-65.44%	205.56%	21.82%
Free Cash Flow (FCF) ¹	-582.4	-300.7	-264.7	-270.4
Change	-	48.37%	11.97%	-2.15%
Announcement Date	2/20/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-1,617.18%	-259.84%	-197.48%	-159.49%
EBIT Margin (%)	-	-1,743.03%	-361.3%	-287.57%	-241.13%
EBT Margin (%)	-	-1,721.69%	-370.11%	-287.62%	-234.32%
Net margin (%)	-1,574.23%	-1,613.92%	-296.11%	-287.62%	-234.32%
FCF margin (%)	-	-463.68%	-204.47%	-149.84%	-122.5%
FCF / Net Income (%)	-	28.73%	69.05%	52.1%	52.28%
Profitability
ROA	-	-	-	-	-
ROE	-	-65.92%	-17.65%	-21.78%	-26.53%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	4.15%	1.22%	3.11%	3.04%
CAPEX / EBITDA (%)	-	-0.26%	-0.47%	-1.58%	-1.9%
CAPEX / FCF (%)	-	-0.89%	-0.6%	-2.08%	-2.48%
Items per share
Cash flow per share ¹	-	-	-	-	-
Change	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-
Change	-	-	-	-	-
Book Value Per Share ¹	-	73.86	60.09	49.52	38.15
Change	-	-	-18.64%	-17.59%	-22.96%
EPS ¹	-	-63.54	-11.86	-11.45	-11.33
Change	-	-	81.33%	3.51%	0.99%
Nbr of stocks (in thousands)	-	33,601	38,982	38,982	38,982
Announcement Date	-	2/20/25	-	-	-